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Background: Patient Data Management Systems (PDMS) support clinical documentation at the bedside and have
demonstrated effects on completeness of patient charting and the time spent on documentation. These systems
are costly and raise the question if such a major investment pays off. We tried to answer the following questions:
How do costs and revenues of an intensive care unit develop before and after introduction of a PDMS? Can higher
revenues be obtained with improved PDMS documentation? Can we present cost savings attributable to the PDMS?
Methods: Retrospective analysis of cost and reimbursement data of a 25 bed Intensive Care Unit at a German
University Hospital, three years before (2004–2006) and three years after (2007–2009) PDMS implementation.
Results: Costs and revenues increased continuously over the years. The profit of the investigated ICU was fluctuating
over the years and seemingly depending on other factors as well. We found a small increase in profit in the year after
the introduction of the PDMS, but not in the following years. Profit per case peaked at 1039 € in 2007, but dropped
subsequently to 639 € per case. We found no clear evidence for cost savings after the PDMS introduction. Our cautious
calculation did not consider additional labour costs for IT staff needed for system maintenance.
Conclusions: The introduction of a PDMS has probably minimal or no effect on reimbursement. In our case the
observed increase in profit was too small to amortize the total investment for PDMS implementation.
This may add some counterweight to the literature, where expectations for tools such as the PDMS can be
quite unreasonable.
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Scientific background
Patient Data Management Systems (PDMS) support bed-
side clinical documentation at intensive care units (ICUs).
They comprise components of computerized physician
order entry (CPOE) such as daily drug and treatment
orders. PDMS implementation costs between 15.000 and
20.000 Euros per bed [1] raise the question if these sys-
tems are cost effective.Rationale for the study
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distribution, and reproduction in any medium(DRG). Grouping patients into ICU-specific DRGs for
reimbursement requires hospitals to document ventila-
tion time, daily modified SAPS II and TISS Score, as well
as several more parameters [2]. Missing or erroneous
coding information leads to loss of revenues. In this
context, Fränkel et al. detected that errors in the paper–
based ventilation time documentation caused 22.7% false
patient groupings in six of seven observed ICUs and
reported an enormous negative cost effect [3]. Since our
PDMS comes with a direct interface for automated venti-
lation time documentation, we assume that a reduction
of missing or erroneous documentation could lead to
visible economic effects, and potentially a return of in-
vestment (ROI) that justifies the implementation costs.
Scanning the literature however, we only found directtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[4] but none for PDMS in ICU.
Objectives of the study
To investigate the mentioned aspects, we performed a
retrospective observational review of the development of
costs and revenues at one of our ICUs to assess the
potential cost benefit of the PDMS:
1. How do costs and revenues of an ICU develop
before and after introduction of a PDMS?
2. Can higher revenues be obtained with improved
PDMS documentation?




Erlangen University Hospital, a tertiary care facility in
southern Germany with 1320 beds, introduced a PDMS
[5]. This study concerns a 25-bed interdisciplinary surgi-
cal ICU, where approximately 2500 patients are treated
per year, with an average length of stay (LOS) of 3.3 days.
A recovery room with 10 beds is attached.
System details and system in use
Beginning in October 2006, a commercial PDMS was
introduced stepwise in each ICU subarea to replace the
former paper based patient chart. This rollout was com-
pleted in December, so we consider 2007 as the first
year with a fully operational PDMS in use. In 2007 and
2009 the PDMS was rolled out to five additional recov-
ery room beds each year.
From January 2007, staff from all professional groups
participated continuously in digital bedside charting of
all patient activities. The PDMS complies with most re-
quirements given in [6], and supports data reuse and
data transfer for accounting purposes to the administra-
tive subsystem. System functions comprise online data
acquisition of vital signs from monitoring devices, from
ventilators and from other medical devices. The PDMS
supports bedside CPOE for orders between physicians
and nursing staff and facilitates calculations of drug
doses and fluid balances [7]. Import interfaces have been
established for laboratory, microbiology and radiology
data, as well as surgery reports. The PDMS supports
automated calculation of ventilation times, automated
scoring and semi-automated coding of diagnoses and
procedures from previously documented clinical data
according to the coding rules of the German DRG sys-
tem. Furthermore, the PDMS offers a specific DRG
workplace functionality to help the physician collect all
data that is relevant for coding. The DRG workplace
includes an interface for exporting DRG data directlyto the electronic billing system of the hospital, thus
avoiding potential transcribing errors. Various reporting
functionalities, views in tabular or graphical format, print-
out functionalities and support for digital photography
documentation are available. Some Arden syntax based
decision support functions for low glucose alerting, ad-
ministrative overviews and calculation of scores have
been added by our workgroup [8].
Methods
Study design
We performed a retrospective observational and explora-
tive analysis of available cost and reimbursement data of
this ICU for a time period of three years before and three
years after system introduction.
Theoretical background
ROI calculations have been published for various elec-
tronic applications in national or international settings,
including outpatient electronic records [9], CPOE sys-
tems [10] and clinical pathways [11]. These calcula-
tions, however, are often based on assumptions and
estimations derived from small study populations with
extrapolation to a larger collective. We scanned the
literature for “effects” and “cost-and-benefit-analysis”
and could not find a single source that demonstrated
cost savings for a PDMS and described a ROI calcula-
tion based on real costs and revenues. Searching for
studies on the PDMS-associated benefits, we located
some reports on time savings [12]. We then widened
our search to “medical information systems” and “com-
puterized physician order entry”, and found sources for
radiology systems comparing film costs directly to the
costs for digital picture archiving [4]. For CPOE systems
some authors [10,13] calculate positive effects such as
avoiding adverse drug events as a financial benefit. There
is, however, no evidence that these revenues have in fact
been realized [14].
Participants
Billing data collected over six years from a 25 bed inter-
disciplinary surgical ICU. All data was obtained from the
SAP billing system of the hospital.
Study flow
Our intention was to obtain stabilized economic data
free from short term fluctuations. The analysis was
conducted retrospectively in 2011, considering uninter-
rupted data from 2004 to 2009. We included all cases
with a stay at the investigated ICU. Patients staying
overnight in the recovery room were likewise treated as
ICU patients, and were thus also included in the analysis.
The German DRG system was introduced in 2003, and its
practical application became mandatory in 2004. In the
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bringing the number of DRGs from 806 (in 2004) to
1147 (in 2009). The PDMS, after its introduction in 2006,
also underwent regular maintenance and one update
per year, which included adaptation to the altered DRG
coding rules.
Outcome measures
The main outcome parameter was the increase or de-
crease in profit for the ICU in the year after introduction
of the PDMS. Profit is calculated as the difference be-
tween reimbursements and costs for patient care at the
ICU, but should not be misinterpreted as economic net
profit. ICUs are part of a complex clinical environment with
reciprocal financing between departments and units. In our
analysis, profit is rather seen as a more general parameter
for measuring and visualizing changes in the economic pro-
cesses over the years. These numbers were compared to
required PDMS investment costs and their amortization.
We included the number of cases, the DRG-based case
mix index, LOS, and the total count of nursing days as
reference parameters.
Methods for data acquisition
We followed the ten point checklist of Drummond [15]
for economic evaluation of healthcare programs except
for the prospective trial design. Cost data was derived
from the hospitals central accounting software using the
standardized annual cost reports of the ICU cost unit.
Reimbursement data was extracted from standardized
monthly controlling reports for the same cost unit. For
reference we also included the German annual inflation
rate available from the German Federal Statistics Bureau.
Costs for the PDMS implementation were split into
investment costs and yearly running costs. Investment
costs are covered by a hospital-wide PDMS implemen-
tation budget and derived from a separate PDMS invest-
ment plan for university hospitals with funding from the
German government. Yearly running costs are chargedTable 1 Total costs and revenues of ICU cost unit
2004 2005
No. cases 1,853 1,744
CaseMixIndex 4.95 5.27
Length of stay [days] 3.7 3.6
Total nursing days 7,365 6,956
Total ICU costs 8,938,352 € 8,910,418 €
Total ICU revenue 8,275,542 € 9,348,546 € 10
Profit −662,810 € 438,128 € 1
German inflation rate 1.6% 1.6%
Profit / case −358 € 251 €
Difference to baseline 2006directly to the ICU and derived from the ICU cost unit
data. Running costs before the PDMS introduction
comprise maintenance charges for the workstations, as
well as costs for some specific data processing applica-
tions in the ICU. After PDMS implementation, current
data processing costs include the ICU’s share in main-
tenance charges payable to the PDMS and database
vendor. Labour costs for clinical and IT staff in the
pre-implementation configuration period have been cal-
culated on basis of allocated working time, and are
included in the investment costs [5]. A person year
was calculated with 220 person days at € 40.000 for
nursing staff, and at € 60.000 for physicians and IT
staff. Costs for additional centralized IT staff required
to maintain the PDMS on meanwhile eight ICUs have not
been included.Methods for data analysis
The average LOS was computed dividing the number
of ICU days by the number of patients in this period.
The case mix index (CMI) in the German DRG system
is calculated by dividing the sum of all cost weights
of the underlying cases (the case mix) by the number
of cases, and can be used as an indirect parameter to
describe the average case severity. All data analysis is
descriptive due to the explorative study design.Results
Demographic and other study coverage data
The essential demographic and cost data is displayed in
Table 1. The number of treated patients (DRG cases) in-
creased from 1,853 to 2,190, associated with a drop of
the average ICU LOS from nearly four to approximately
three days. CMI rises from 4.95 in 2004 to a maximum
of 6.3 in 2007 dropping back to 5.89 in 2009. The total
number of nursing days fluctuates between 6,830 and
7,365 per year. In comparison with other countries, the
German inflation rate is fairly low between 0.3 and 2.6%.2006 2007 2008 2009
1,670 1,662 2,056 2,190
5.80 6.30 5.79 5.89
3.8 3.6 3.1 3.0
7,102 6,830 6,946 7,022
9,212,039 € 9,360,012 € 10,129,576 € 10,583,335 €
,810,164 € 11,087,202 € 11,444,147€ 12,270,127€
,598,125 € 1,727,190 € 1,314,571 € 1,686,793 €
1.5% 2.3% 2.6% 0.3%
957 € 1039 € 639 € 770 €
129,065 € −283,544 € 88,668 €
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We did the same database queries for reimbursement
data several times and noticed that we were unable to
obtain reproducible results until at least two years after
finishing an observation period. It proved extraordinarily
complicated to calculate the true revenues of the ICU
for patients who were later discharged from another
surgical unit, because their reimbursements were not
assigned to the ICU in the hospital’s billing system.
Study findings and outcome data
Table 1 lists total costs and revenues for the investigated
ICU. Total costs and revenues of the ICU increased from
8.9 million to 10.6 respectively 8.3 to 12.3 million Euros.
Net profit increased from 1.598 million in 2006 to 1.727
million € in 2007. Thus, a difference of 129,065 € could
potentially have been caused by the PDMS. In 2008, net
profit was lower than in 2006 and rose again in 2009.
Profit per case revealed a major gain in the years 2004
to 2006 (prior to PDMS) peaking at 1,039 € per case in
2007, followed by a drop to 639 € per case in 2008 and
770 € per case in 2009. This trend coincided with the
development of the CMI described above.
Table 2 lists ICU data processing expenses incurred in
the years 2004–2009. Investment costs were covered
from the German government while current data pro-
cessing costs must be compensated with revenues from
patient care. The first row illustrates the investment
costs for the 25 beds ICU incurred in 2006 and further
investment costs for the ten bed recovery room which
was later equipped with the PDMS.
These costs soared to around € 80,000, but then fell
back in 2009 when more ICUs of the hospital introduced
the same PDMS, resulting in decreased costs per client.
Note: Costs for additional IT staff in the central IT
department for PDMS maintenance are not included,
because these are not billed directly to the ICU.
Considering the total investment sum for PDMS
implementation (936,896 €), the small profit gain does
not permit amortization.
Unexpected observations
We did not expect costs and revenues to increase as
much as they did. Over six years costs grew by 16% and
revenues by 33%, which is far above inflation rate. Vari-
ables such as patient numbers or the CMI (whichTable 2 Data processing costs split in investment costs and c
2004 2005
Investment costs 826
Current costs 23,765 € 16,081 € 23
Total costs 23,765 € 16,081 € 849increased from an average of 5.34 to 5.99), grew notably
after 2007. This may help to identify confounding fac-
tors such as increased disease severity or changing ICU
assignments. It is certainly remarkable that yearly reve-
nues ranged between 662,810 € loss and 1,727,190 € net
profit. The biggest rise to around 1.6 million € profit,
however, emerged between 2005 and 2006, one year
before PDMS introduction.
Discussion
Answer to study questions
To the best of our knowledge, we are the first to present
a ROI calculation for a PDMS based on actual costs and
revenues of an ICU. We found:
1. A considerable increase of costs and reimbursement
over six years, which was largely unaffected by
PDMS introduction.
2. A small increase of 129,065 € profit between the
years 2006 and 2007 which could have been
attributable to the PDMS.
3. No net cost savings when comparing the
considerable investment costs with the mentioned
potential effect on revenue.
Considering previous reports with 22.7% erroneous
patient groupings due to faulty paper-based ventilation
time documentation [3] the use of the PDMS has likely
eliminated a majority of potential errors for this type of
data. Ventilation time is measured automatically from
values imported from the ventilator interface. Appropri-
ate procedure codes are proposed based on this data in
the DRG workplace. All ventilation periods plus codes
are digitally transferred to the billing system. Neverthe-
less, this specific financial effect of PDMS introduction
was marginal when compared to other effects such as
the general increases in the CMI and costs and reim-
bursements. Profit per case increased by 82 € but was
lower in all subsequent years, indicating that the PDMS
probably did not create sustained financial impact.
Assuming the full benefit of 129,065 € is due to the
PDMS, the amortization of nearly one million Euro
total investment would exceed six years and therefore
was not calculated. Besides, our calculation omits costs
for additional central IT staff required for support and
maintenance of the PDMS. Extra IT staff is needed inurrent costs
2006 2007 2008 2009
,000 € 73,636 € 37,260 €
,068 € 70,136 € 80,459 € 54,482 €
,068 € 143,772 € 80,459 € 91,742 €
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which requires high system availability.Strengths and weaknesses of the study
We present a straight-forward method that permits to
exclude major monetary effects of an information system
based on continuous analysis of cost and reimbursement
data over several years before and after system introduc-
tion. Things become more complicated in situations when
a major profit increase is found, because then it remains
unclear to which degree it can be attributed to the system
or confounding factors. To cover such outcomes we have
included an (incomplete) set of reference parameters
such as CMI and number of cases which can be used to
calculate relative values or fractions such as profit per
case. We note the presence of confounding factors in
our study such as the strong increase in CMI, costs
and reimbursement between 2004 and 2006. These
observations may be attributable either to more com-
plicated patient cases or to changes in the German
DRG system which evolved in these years to reflect
the higher expenses incurred on ICUs. Other potential
confounding factors include changes in ICU organi-
zation, management and strategy, reflected in increas-
ing numbers of cases and decreasing length of stay
within the total observation period.
In our design we did not measure other potential system
benefits such as avoidance of medical errors or reduction
of adverse drug events. Therefore our conservative ap-
proach may underestimate the benefits of the new PDMS
compared to [10,16-18].Results in relation to other studies
As mentioned, we were unable to detect any study meas-
uring real costs and reimbursement before and after the
deployment of a PDMS. We found a variety of publica-
tions dealing with introduction of other medical infor-
mation systems such as PACS, CPOE or CDSS. It is
remarkable that even those publications rarely report
actual costs and revenues. Instead, many authors meas-
ure or estimate benefits of the system, such as time
savings or prevented adverse drug effects, and only cal-
culate the potential financial benefit by extrapolation
[4,10,12,17]. This may result in over- or underestima-
tion of the system benefits. PDMS-centered studies such
as [10,17,18] tend to concentrate on other positive system
effects, such as an avoidance of medical errors and a re-
duction of adverse drug events. Stürzlinger and colleagues
[19] published a review on several health technology as-
sessment studies centered on CPOE introduction and
found that CPOE benefits remain questionable, which
fits nicely with our results. In their review, many studies
were reported to have methodological flaws.Meaning and generalizability of the study
The method presented here can be easily reproduced
at other institutions and for other types of information
systems, if a continuous database for cost and reimburse-
ment data is available for several years before and after
system introduction. Potential confounding factors such
as the number of cases, disease severity, staffing and
organizational changes should be recorded in parallel.
A monetary effect of the system can most likely be ex-
cluded if no relevant increase in profit after system
introduction is found.
Unanswered and new questions
It remains an open question if publications such as [3]
have overestimated the effect of improved documenta-
tion, or if positive system effects have potentially been
compensated by other negative effects in 2007. For future
studies the collection of the most appropriate confounding
factors and the assessment of their calculatory effects is
a demanding task to better differentiate between system
effects and side effects. These parameters must be com-
parable among different institutions and, most essen-
tially, they must be available in good quality for a period
of time before (!) and after the system introduction. This
limits the selection of measured confounding parame-
ters strongly, precisely because many relevant parame-
ters are difficult to obtain completely for all patients
before electronic documentation is deployed. Similar to
measured quality parameters or system effects, confounding
factors can be grouped according to Donabedian into the
categories structure, process and outcome parameters [20].
Economic evaluation concerns outcome in terms of de-
creased expenditure, increased reimbursement or a com-
bination of both. Therefore outcome parameters should
also be considered in future research. These include
mortality, LOS and ventilator time. Confounding process
parameters have to be included as well. We measured the
number of cases and disease severity using the CMI, but
this economic parameter is simultaneously influenced by
the quality of coding and managerial decisions. Unfortu-
nately, the same can be said about many other parameters
measuring disease severity. In the future, it may be better
to use clinical scoring systems such as APACHE II or
SAPS II. Furthermore, it may be advisable to consider
also staffing, the number of admitted/discharged patients
per day and other similar parameters to assess undesired
effects influencing the cost data.
Generally, it is difficult to obtain conclusive results
in evaluation studies of clinical information systems where
only one evaluation method is applied. Therefore, multi-
method evaluations, which combine different aspects such
as documentation quality or time measurements with the
described cost data analysis, are desirable. A prospective
study design would be required to confirm our findings.
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Economic validation of healthcare information systems
is an on-going work. The introduction of a PDMS has
probably marginal or no effects on reimbursement. In
our case the observed increase in profit was too small
to amortize the total investment. This may add some
counterweight to the literature, where expectations for
tools such as the PDMS can be quite unreasonable.
More studies are needed and evaluation methods must
be improved to demonstrate that often postulated posi-
tive PDMS effects have in fact been realized. Consider-
ing the evaluation methodology, we were astonished to
find few standardized or typical parameters which may
be directly compared between different institutions. We
hope that our approach may prompt more institutions
to publish comparable data.
Human subjects protections
This was an economical study analyzing economic effects
before and after PDMS implementation on an intensive
care unit with the aim of calculating a return of invest-
ment time. No formal intervention was performed. No
additional patient data was collected. In according with
German Bavarian Hospital Law (BayKrg §27) observational
studies which do not collect additional patient data beyond
routine documentation may use anonymized patient docu-
mentation without additional patient consent.
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